# US 2024/0254523 A1 · Genetically engineered strain for producing polylactic acid and method for producing polylactic acid

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2024/0254523 A1
- Document ID: US20240254523A1
- Status: Published application
- Kind: A1
- Application number: 18/607,573
- Filed: 2024-03-18
- Published: 2024-08-01
- Earliest claimed: 2021-09-29
- Assignees: Shanghai Sipeng Technology Ltd.
- Applicants: Shanghai Sipeng Technology Ltd.
- Inventors: Fei TAO; Chunlin TAN; Ping XU
- Web page: https://patentgrep.com/patent/US20240254523A1

## CPC

- C12P 7/625: Polyesters of hydroxy carboxylic acids
- C12N 9/0006: {acting on CH-OH groups as donors (1.1)}
- C12N 9/001: {acting on the CH-CH group of donors (1.3)}
- C12N 9/1029: {transferring groups other than amino-acyl groups (2.3.1)}
- C12N 9/1217: {Phosphotransferases with a carboxyl group as acceptor (2.7.2)}
- C12N 9/13: {transferring sulfur containing groups (2.8)}
- C12N 9/93: {Ligases (6)}
- C12N 15/52: Genes encoding for enzymes or proenzymes
- C12N 15/74: Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
- C12P 7/62: Carboxylic acid esters
- C12Y 101/01027: L-Lactate dehydrogenase (1.1.1.27)
- C12Y 101/01028: D-Lactate dehydrogenase (1.1.1.28)
- C12Y 203/0118: Beta-ketoacyl-acyl-carrier-protein synthase III (2.3.1.180)
- C12Y 207/02001: Acetate kinase (2.7.2.1)
- C12Y 208/03001: Propionate CoA-transferase (2.8.3.1)
- C12Y 602/01001: Acetate-CoA ligase (6.2.1.1)
- C12Y 604/01002: Acetyl-CoA carboxylase (6.4.1.2)
- Y02P 20/141: Feedstock
- C12P: FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE {(brewing of beer C12C; producing vinegar C12J; producing specific peptides or proteins C07K; producing enzymes C12N9/00; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification C12N15/00; measuring or testing processes involving enzymes or microorganisms C12Q; measuring or testing processes involving nucleic acid amplification reactions C12Q1/6844; fermentation processes to form a food composition, A21 or A23; compounds in general, see the relevant compound class, e.g. C01, C07)}
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C12Y: ENZYMES
- Y02P: CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS

## Abstract

Provided are a genetically engineered strain for producing polylactic acid and a method for producing polylactic acid. The genome of the genetically engineered strain is integrated with a coding sequence of exogenous D-lactate dehydrogenase gene, a coding sequence of exogenous propionyl-CoA transferase gene, and a coding sequence of exogenous polyhydroxyalkanoate synthase gene, enabling the genetically engineered strain to express exogenous D-lactate dehydrogenase, exogenous propionyl-CoA transferase, and exogenous polyhydroxyalkanoate synthase. The method includes: providing the above genetically engineered strain of Synechococcus elongatus; introducing carbon dioxide and culturing the genetically engineered strain under light; and when a growth OD of the genetically engineered strain reaches the maximum, collecting and drying the genetically engineered strain, and recycling the polylactic acid in the strain.

## Claims

### Claim 1

A genetically engineered strain of Synechococcus elongatus, wherein the genome of the genetically engineered strain is integrated with a coding sequence of exogenous D-lactate dehydrogenase gene, a coding sequence of exogenous propionyl-CoA transferase gene, and a coding sequence of exogenous polyhydroxyalkanoate synthase gene, enabling the genetically engineered strain to express exogenous D-lactate dehydrogenase, exogenous propionyl-CoA transferase, and exogenous polyhydroxyalkanoate synthase.

### Claim 2 (depends on 1)

The genetically engineered strain according to claim 1, wherein the coding sequence of D-lactate dehydrogenase gene is under the control of a Pi, promoter, a Ppsba promoter, or a Pcpc560 promoter.

### Claim 3 (depends on 1)

The genetically engineered strain according to claim 1, wherein the coding sequence of propionyl-CoA transferase gene is under the control of a Ptrc promoter, a Ppsba promoter, or a Pcpc560 promoter.

### Claim 4 (depends on 1)

The genetically engineered strain according to claim 1, wherein the coding sequence of polyhydroxyalkanoate synthase gene is under the control of a Ptrc promoter, a Ppsba promoter or a Pcpc560 promoter.

### Claim 5 (depends on 1)

The genetically engineered strain according to claim 1, wherein:
the coding sequence of exogenous D-lactate dehydrogenase gene is derived from Lactobacillus bulgaricus;
the coding sequence of exogenous propionyl-CoA transferase gene is derived from Clostridium propionicum; and
the coding sequence of exogenous polyhydroxyalkanoate synthase gene is derived from Pseudomonas.

### Claim 6 (depends on 1)

The genetically engineered strain according to claim 1, wherein the genome of the genetically engineered strain is integrated with a coding sequence of exogenous acetyl-CoA synthase gene, enabling the genetically engineered strain to express the exogenous acetyl-CoA synthase gene.

### Claim 7 (depends on 1)

The genetically engineered strain according to claim 1, wherein expression of acetate kinase gene in the genetically engineered strain is knocked down.

### Claim 8 (depends on 7)

The genetically engineered strain according to claim 7, wherein the genome of the genetically engineered strain is integrated with a coding sequence of exogenous sRNA capable of inhibiting the expression of acetate kinase gene.

### Claim 9 (depends on 1)

The genetically engineered strain according to claim 1, wherein expression of acetyl-CoA carboxylase gene, expression of ketosynthase gene, and/or expression of beta-ketoacyl-ACP synthase III gene in the genetically engineered strain are knocked down.

### Claim 10 (depends on 9)

The genetically engineered strain according to claim 9, wherein the genome of the genetically engineered strain is integrated with a coding sequence of exogenous sRNA capable of inhibiting the expression of acetyl-CoA carboxylase gene, the expression of ketosynthase gene, and/or the expression of beta-ketoacyl-ACP synthase III gene.

### Claim 11 (depends on 1)

The genetically engineered strain according to claim 1, wherein the genetically engineered strain is a Synechococcus elongatus PCC 7942 strain.

### Claim 12

A method for producing polylactic acid using carbon dioxide, the method comprising:
1) providing a genetically engineered strain of Synechococcus elongatus, wherein the genome of the genetically engineered strain is integrated with a coding sequence of exogenous D-lactate dehydrogenase gene, a coding sequence of exogenous propionyl-CoA transferase gene, and a coding sequence of exogenous polyhydroxyalkanoate synthase gene, enabling the genetically engineered strain to express exogenous D-lactate dehydrogenase, exogenous propionyl-CoA transferase, and exogenous polyhydroxyalkanoate synthase;
2) introducing carbon dioxide and culturing the genetically engineered strain under light; and
3) when a growth OD of the genetically engineered strain reaches the maximum, collecting and drying the genetically engineered strain, and recycling the polylactic acid in the strain.

### Claim 13 (depends on 12)

The method according to claim 12, wherein in step 2), the carbon dioxide is introduced with a ventilation rate of 1.5 vvm, and a volume ratio of introduced carbon dioxide to air is 1:
(1 to 10).

### Claim 14 (depends on 12)

The method according to claim 12, wherein in step 2), an intensity of the light is from 125 μmol photons m−2 s−1 to less than 1000 μmol photons m−2 s−1, and preferably, the intensity of the light ranges from 125 μmol photons m−2 s−1 to 500 μmol photons m−2 s−1.

### Claim 15 (depends on 12)

The method according to claim 12, wherein in step 2), the genetically engineered strain is cultured in a culture medium comprising sodium carbonate, sodium nitrate, dipotassium hydrogen phosphate, magnesium sulfate, calcium chloride, citric acid, ferric ammonium citrate, ethylenediamine tetraacetic acid, boric acid, manganese chloride, zinc sulfate, sodium molybdate, copper sulfate, and cobalt nitrate.

### Claim 16 (depends on 15)

The method according to claim 15, wherein Na2CO3, MgSO4-7H2O, NaNO3, KH2PO4, and trace elements are further added to the formula of the culture medium, and preferably, the trace elements are selected from H3BO3, MnCl2·7H2O, ZnSO4·7H2O, Na2MoO4·2H2O, CuSO4·5H2O, and Co(NO3)2·6H2O.

### Claim 17 (depends on 15)

The method according to claim 15, wherein a final concentration of the sodium carbonate in the culture medium ranges from 0.25 g/L to 1.5 g/L.

### Claim 18 (depends on 12)

The method according to claim 12, wherein in step 2), the genetically engineered strain is cultured in the presence of an inducer, and preferably, the inducer is selected from one or more of IPTG and theophylline.

### Claim 19 (depends on 12)

The method according to claim 12, wherein in step 3), said collecting the genetically engineered strain comprises:
mixing a polyelectrolyte flocculant with a culture solution containing the genetically engineered strain for 5 minutes, standing for 5 minutes, discarding a supernatant, and collecting a precipitate, and
preferably, the polyelectrolyte flocculant is a polyacrylamide flocculant.

### Claim 20 (depends on 12)

The method according to claim 12, wherein in step 3), said recycling the polylactic acid in the strain is performed by using an organic solvent recycling or an inorganic aqueous phase extraction method, and
preferably, the organic solvent is selected from chloroform, 1,4-epoxydioxane, methyl-tetrahydrofuran, ethylene carbonate, acetone, and ethyl acetate.
